Institute of Social Sciences, Belgrade, Serbia.
Institute of Social Sciences, Belgrade, Serbia.
Ann Epidemiol. 2023 Aug;84:41-47. doi: 10.1016/j.annepidem.2023.05.006. Epub 2023 May 15.
Since the start of the COVID-19 pandemic, countries have scrambled to set up data collection and dissemination pipelines for various online datasets. This study aims to evaluate the reliability of the preliminary COVID-19 mortality data from Serbia, which has been included in major COVID-19 databases and utilized for research purposes worldwide.
Discrepancies between the preliminary mortality data and the final mortality data in Serbia were analyzed. The preliminary data were reported through an emergency-necessitated system, while the final data were generated by the regular vital statistics pipeline. We identified databases that include these data and conducted a literature review of articles that utilized them.
The number of deaths due to COVID-19 in Serbia, as reported preliminarily, does not align with the final death toll, which is more than three times higher. Our literature review identified at least 86 studies that were impacted by these problematic data.
We strongly advise researchers to disregard the preliminary COVID-19 mortality data from Serbia due to the significant discrepancies with the final data. We recommend validating any preliminary data using excess mortality if all-cause mortality data are available.
自 COVID-19 大流行开始以来,各国竞相建立各种在线数据集的数据收集和传播管道。本研究旨在评估塞尔维亚初步 COVID-19 死亡率数据的可靠性,这些数据已被纳入主要的 COVID-19 数据库,并在全球范围内用于研究目的。
分析了塞尔维亚初步死亡率数据与最终死亡率数据之间的差异。初步数据是通过应急系统报告的,而最终数据是由常规生命统计管道生成的。我们确定了包含这些数据的数据库,并对使用这些数据的文章进行了文献综述。
塞尔维亚初步报告的 COVID-19 死亡人数与最终死亡人数不符,后者高出三倍多。我们的文献综述确定了至少 86 项受到这些有问题数据影响的研究。
由于与最终数据存在显著差异,我们强烈建议研究人员不要使用塞尔维亚的初步 COVID-19 死亡率数据。如果有全因死亡率数据可用,我们建议使用超额死亡率来验证任何初步数据。